HomePeptidesMOTS-c
Peptide research profile

MOTS-c

Also known as mitochondrial open reading frame of the 12S rRNA type-c · mots · motsc

Animal and cellular work suggests metabolic signaling effects, but studies measuring naturally circulating MOTS-c in people do not prove that administered MOTS-c is effective or safe.

Very low evidenceNot FDA approved
Evidence maturity
Early signal
Regulatory status
Not FDA approved
Recorded outcomes
3
Indexed sources
3
Educational information—not medical advice.

This profile does not recommend a compound, dose, supplier, or treatment plan. Discuss personal decisions with a qualified clinician who knows your history.

Summary

A mitochondrial-derived peptide whose therapeutic evidence remains predominantly preclinical.

What is MOTS-c being studied for?

Metabolic signaling and longevity research

How is it thought to work?

Preclinical models propose folate-linked purine-synthesis inhibition, AICAR accumulation, AMPK activation, and skeletal-muscle metabolic effects.

Recorded outcomes

Free account

3 graded outcomes and 3 sources for MOTS-c.

The graded outcome table, how each grade was decided, the regulatory detail, and every source with its link and identifier open with a free account. No payment details required.

Update history

  • Editorial review of the profile and its sources.
  • Record last updated in the Senzu database.
  • Profile first published.
Keep asking better questions

Research should make the decision clearer—not make it for you.

Explore another profile

Before you continue

Senzu is an independent research reference. We document the peptide market — vendor listings, third-party lab records, and published research. We do not sell peptides, and nothing here is medical advice or a dosing recommendation.

A listing is not an endorsement, a safety certification, or a statement that a product is legal or approved where you live. Most compounds documented here are not approved by the FDA or MHRA for the uses discussed.